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ABSTRACT
The aims of this systematic review were to assess the 
clinical relevance and quality of previously published 
animal models of ischemic ulceration and examine the 
available evidence for interventions improving ulcer 
healing in these models. Publicly available databases 
were searched for original studies investigating the 
effect of limb ischemia on wound healing in animal 
models. The quality of studies was assessed using two 
tools based on the Animal research: Reporting of In Vivo 
Experiments (ARRIVE) guidelines and the clinical relevance 
of the models. A total of 640 wounds (ischemic=314; 
non- ischemic=326) were assessed in 252 animals (92 
mice, 140 rats, 20 rabbits) from 7 studies. Meta- analyses 
showed that wound healing was consistently delayed by 
ischemia at all time- points examined (day-7 standard 
median difference (SMD) 5.36, 95% CI 3.67 to 7.05; 
day-14 SMD 4.50, 95% CI 2.90 to 6.10 and day-21 SMD 
2.53, 95% CI 1.25 to 3.80). No significant difference in 
wound healing was observed between 32 diabetic and 
32 non- diabetic animals with ischemic wounds. Many 
studies lacked methods to reduce bias, such as outcome 
assessors blinded to group allocation and sample size 
calculations and clinically relevant model characteristics, 
such as use of older animals and a peripheral location of 
the wound. Five different interventions were reported to 
improve wound healing in these models. The impaired 
wound healing associated with limb ischemia can be 
modeled in a variety of different animals. Improvements in 
study design could increase clinical relevance, reduce bias 
and aid the discovery of translatable therapies.
INTRODUCTION
Chronic wounds, or ulcers, are a worldwide 
problem estimated to affect about 1%–2% 
of the population and an important contrib-
utor to disability and early mortality.1 2 Treat-
ment of ulcers is expensive. In the USA, for 
example, it has been estimated that the cost 
of managing diabetes- associated foot ulcers is 
between US$28.1 and 96.8 billion per year.3 
The 5- year mortality of people with diabetes- 
associated lower limb ulcers is comparable to 
some cancers.4
Ischemia plays an important role in the 
etiology of about a quarter of ulcers.5 6 Isch-
emic ulcers are frequently very difficult to 
heal and are an important cause of major 
lower limb amputation.7 Ischemic ulcers are 
usually managed by open or endovascular 
revascularization surgery. Revasculariza-
tion, however, has a number of deficiencies, 
including a risk of perioperative complica-
tions, failure to successfully heal the ulcer and 
lack of suitability for some patients.8 9 There is 
therefore a need for alternative and adjunc-
tive therapies.10 11
Animal models of ischemic ulcers are 
needed to test potential new therapies. 
For preclinical studies to be valuable, it is 
important that the animal models mimic the 
underlying pathophysiological mechanisms 
for delayed wound healing seen in patients. 
Currently, there is no consensus on which 
animal model best represents human lower 
limb ischemic ulcers. The focus of this study 
was to systematically review the published 
animal models of ischemic ulcers. The first 
aim was to assess whether there was evidence 
that the published animal models simulate 
the ability of ischemia to delay wound healing. 
The second aim was to assess the relevance 
of available animal models to patients and 
examine the quality of past animal research. 
The third aim was to assess what evidence 
there was for the efficacy of different inter-
ventions to heal ischemic wounds within the 
animal models examined. The intention was 
to inform the most appropriate model of 
ischemic ulceration for future research and 
advance the approach to research designed to 
develop new treatments for ischemic ulcers.
METHODS
Search strategy
This systematic review was performed 
according to the 2015 Preferred Reporting 
Items for Systematic Review and Meta- 
Analysis Protocols (PRISMA- P) statement.12 
The protocol was registered in the PROS-
PERO database (Registration Number: 
CRD42020126521). The literature search 
was conducted by one author (ST) to iden-
tify animal studies that evaluated the effect 
of ischemia on wound healing in animal 
models. The databases PubMed, Scopus and 
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relevant publications until the 23 February. The search 
strategy used both medical subject headings (MeSH) and 
keywords as given in the online supplementary data.
Inclusion and exclusion criteria
Included articles were identified by one author (ST). 
Studies included were reported as original articles 
comparing wound area of ischemic and non- ischemic 
ulcers in animal models that were published in the 
English language. Only ischemia induced through 
ligation of the femoral, iliac or saphenous arteries and 
wounds created through excision methods in the extrem-
ities were included to represent the clinical setting. Exclu-
sions included clinical studies, reviews or case reports.
Data extraction
The full texts of included studies were independently 
assessed by two investigators (ST and JP) to extract data 
on animal species, age, sex, weight and number, method 
of ischemia and wound induction, wound area at days 7, 
14 and 21. Extracted data were discussed in a meeting 
with another researcher (JG) and finally agreed through 
consensus. In studies where numerical data of wound 
area was not reported, the corresponding authors of the 
studies concerned were contacted to obtain original data. 
In studies where the data was unobtainable, a screenshot 
of the graphical data was exported into ImageJ V.1.48 
(National Institutes of Health, USA) and relevant values 
were extracted. From the screenshot, the length covered 
between the base of the graph to the plotted area of day 
0 of the respective group was calculated as the baseline 
wound area and the relative percentage change in the 
length covered in the graph at the plotted points of day 
7, 14 and 21 of respective groups were calculated and 
the results were presented in terms of percentage. In 
studies where SE of the mean (SEM) was provided, SD 
was manually calculated by multiplying the square root 
of number of animals used in the study to the SEM value. 
If no p value were reported, a two tailed unpaired t test 
was performed using Graphpad Prism 7 (San Diego, Cali-
fornia, USA) where there was evidence of normal distri-
bution of data reported in the original study.
Quality assessment
Each included study was assessed for risk of bias and 
reporting quality and clinical relevance by one researcher 
(ST). Risk of bias and reporting quality was assessed using 
the Animal research: Reporting of In Vivo Experiments 
(ARRIVE) guideline criteria.13 Each study was assessed 
as to whether the following items were reported: ethics 
statement, study design, animal characteristics, detailed 
experimental procedure, animal randomization to 
different groups, experimental measurements of wound 
area, baseline wound area data for comparison, data 
estimates reported as mean or median with variance, 
statistical analysis used and adverse events. The clinical 
relevance of the models were assessed in relation to the 
following parameters: the location of the ischemic wound 
in the peripheral part of the limb, the presence of comor-
bidities (diabetes and older age) and whether complete 
wound healing data were reported. In both risk of bias 
and reporting quality and clinical relevance assessments, 
scoring was answered in binary form (yes=1/no=0) and 
reported in terms of percentage. Studies with scores less 
than 50%, 50%–80% and >80% were considered as low, 
moderate and high quality, respectively.
Outcomes and data analysis
The primary outcome was the healing rate in ischemic 
compared with non- ischemic wounds. Wound healing was 
estimated using extracted wound area data at 7, 14 and 21 
days. Wound area was compared with baseline in terms of 
percentage and the relative wound area at different time- 
points were compared between ischemic and non- ischemic 
animals during healing. The secondary outcome of the 
number of days taken for full closure of wounds were also 
compared between the ischemic and non- ischemic animals. 
The third outcome was to compare healing rate and wound 
closure between animals receiving an interventional agent, 
or with an induced comorbidity, with controls. A minimum 
of three studies at any given time- point were required to be 
eligible for meta- analysis. Meta- analyses were performed 
using Review Manager 5.3.5 (Copenhagen: The Nordic 
Cochrane Centre, The Cochrane Collaboration, 2014). 
Due to anticipated statistical heterogeneity, random- effects 
models were used. Data were expressed as standardized mean 
difference (SMD) with 95% CI. Leave one out sensitivity 
analyses, by removing studies individually, were performed 
to assess the consistency of findings. The I2 index was used 
to assess the degree of heterogeneity between studies, with 
I2>50% accepted to denote statistical heterogeneity. Funnel 
plots of the effect size versus the SEM of the log- transformed 
effect were constructed to assess potential publication bias. 
P<0.05 was considered as statistically significant.
RESULTS
Study selection
Of 5844 screened studies, a total of 7 were included 
(online supplementary figure 1).14–20
Study characteristics
The included studies investigated mouse (n=3),15 19 20 rat 
(n=3)14 17 18 and rabbit (n=1)16 ischemic ulcer models. All 
included studies induced hind limb ischemia by ligating 
either the femoral (n=5)15 17–20 or external iliac (n=2)14 16 
arteries (online supplementary table 1).
Five studies investigated ischemic ulcers in animals where 
diabetes was also induced by intraperitoneal injection of 
streptozotocin (STZ).15 17–20 Wounds were created immedi-
ately following ischemia induction in all studies except one 
where the wound induction was performed 3 weeks after the 
ischemia surgery.16 No other comorbidities were induced 
within any of the included studies. Wounds were created in 
either the dorsal (n=5) or lateral (n=2) surface of the thigh 
(n=4)15 16 19 20 or the paw (n=3).14 17 18 All data were reported 


















are: first published as 10.1136/bm





3BMJ Open Diab Res Care 2020;8:e001676. doi:10.1136/bmjdrc-2020-001676
Pathophysiology/complications
Risk of bias and reporting quality of the included studies
An ethics statement, study design with ischemic and 
non- ischemic comparison groups, animal characteristics 
including age, sex and strain, experimental procedures 
including ischemia and wound creation protocols, wound 
area data and complete wound closure time for both compar-
ison groups at baseline and available time- points (day 7, 14 
and/or 21), and statistical analyses were reported in most 
included studies (table 1). Random allocation of animals to 
the different groups was reported in only one study16 and 
assessment of outcomes by an observer blinded to group allo-
cation was reported in two studies.15 16 Five of the included 
studies were considered of high quality14 16 17 19 20 and two 
were considered of moderate quality.15 18 The mean quality 
assessment score was 77.1%±10.8%.
Clinical relevance of the included studies
As determined by the inclusion criteria, all studies reported 
ischemic wounds in the hind limb region (table 2). Only 
three studies created wounds in the paw region that was 
considered to represent the clinically relevant periph-
eral site.14 17 18 Patients with ischemic wounds typically 
have comorbidities, such as diabetes and older age, which 
contribute to delay wound healing. Five of the seven 
studies investigated ischemic wound in which diabetes was 
induced.15 17–20 Glucose levels were reported in only three of 
these studies.15 19 20 The relative age of the animals studied 
was not comparable to patients ranging from 90 days in 
rats to 8 weeks in mice (online supplementary table 1). 
Blood flow in the ischemic limb was measured using laser 
Doppler imaging in four studies,14 15 17 18 but not reported 
in the remaining three studies16 19 20 (table 2). Three studies 
Table 1 Risk of bias and reporting quality assessment using the ARRIVE guidelines
Criteria
Study
14 15 16 17 18 19 20
Method   
  Ethical statement Reported the ethics committee approval 1 1 1 1 1 1 1
  Study design Reported control vs Ischemia group 1 1 1 1 1 1 1
  Animal 
characteristics
Animal age/weight 1 0 1 1 0 1 1
Sex 1 0 1 1 0 1 1
Strain 1 1 1 1 0 1 1
  Experimental 
procedures
Detailed the ischemia protocol 1 1 1 1 1 1 1
Detailed the wound development 
protocol
1 1 1 1 1 1 1
  Animal 
randomization to 
different groups
Indicated methods employed to minimize 
selection bias between groups
0 0 1 0 0 0 0
  Statistics Reported the statistical methods used 
for each analysis
1 1 1 1 1 1 1
  Experimental 
measurements
Reported the process employed for 
measurement of wound area
1 1 1 1 1 1 1
Reported that the wound measurements 
were performed in duplicates or blinded 
to confirm reliability
0 1 1 0 0 0 0
Results   
  Baseline data Reported baseline data for all animal 
groups
1 1 1 1 1 1 1
  Numbers analyzed Reported the absolute number of 
animals used in each group
1 0 1 1 1 1 1
  Data estimation Reported the results of analysis with a 
measure of precision (SD or SEM)
1 1 1 1 1 1 1
  Adverse events Reported if there was no/any adverse 
events or infection arising from the 
wounds
0 0 0 0 0 0 0
Score of 15=100% 12 10 14 12 9 12 12
Total score (%) 80 66.6 93.3 80 60 80 80
1=Yes; 0=No.
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reported data on full wound closure, which was considered 
a clinically relevant outcome.14 17 18 The clinical relevance of 
the models was considered moderate in three studies14 17 18 
and low in remaining four studies.15 16 19 20 The mean clinical 
relevance score was only 46.1%±17.5%.
Effect of ischemia on wound healing
A total of 640 wounds (Ischemic=314; Non- ischemic=326) 
were assessed from all included studies at days 7 (n=252), 
14 (n=244) and 21 (n=144) in 252 animals (92 mice, 140 
rats, 20 rabbits) from 7 included studies. Diabetes was 
present as a comorbidity in 322 wounds (Ischemia=161; 
Non- ischemia=161) during assessments performed at days 
7 (n=144), 14 (n=136) and 21 (n=42). All included studies 
reported wound area at days 7 and 14,14–20 whereas four 
studies reported wound area at day 21.14 16–18 All time- points 
were eligible for meta- analysis. Wound healing was consis-
tently delayed by ischemia at all time- points (day 7 SMD=5.36 
(95% CI 3.67 to 7.05), day 14 SMD=4.50 (95% CI 2.90 to 
6.10) and day 21 SMD=2.53 (95% CI 1.25 to 3.80), figure 1).
Comparisons of wound healing between diabetic and 
non- diabetic groups in the presence of ischemia were 
eligible for meta- analysis at time- points of day 7 and 14. 
This analysis suggested that diabetes did not significantly 
delay wound healing (online supplementary figures 2 and 
3). The number of studies reporting data at day 21 was less 
than three and therefore data from this time- point were not 
eligible for meta- analysis.
Effect of ischemia on complete wound closure
Three studies reported the number of days taken for 
complete closure of the wounds.14 17 18 Alizadeh et al14 
reported that the wound was completely closed by day 17 
in all animals within the non- ischemic group as compared 
with day 27 in the ischemic group. Tobalem et al17 reported 
that, under normoglycemic condition, full wound closure 
took a mean of 19.3±2.11 days in ischemic as compared 
with 15.1±1.05 days in non- ischemic wounds (p<0.05). On 
the other hand, under hyperglycemic condition, ischemic 
ulcers took a mean of 36±8.73 days to heal as compared with 
17.2±1.32 days for non- ischemic wounds (p<0.05) respec-
tively. Andre- Levinge et al18 reported that non- ischemic 
wounds closed in a mean of 27.3±3.1 days as compared 
with 33.4±7.6 days for ischemic wounds (p=0.002) under 
normoglycemic condition. The meta- analysis showed that 
ischemia significantly delayed the time to full wound closure 
(SMD=1.97 (95% CI 1.59 to 2.34)) (online supplementary 
figure 4).
Effect of interventions on ischemic wounds
Five of the included studies investigated the effect of 
different interventions on wound healing and reported 
significant improvement in healing under both diabetic 
and non- diabetic conditions (table 3). These interven-
tions included hyperbaric oxygen therapy,18 angiogenic 
self- assembling nanofiber hydrogel scaffold seeded with 
Akkermansia muciniphila,19 bone marrow aspirate and 
peripheral blood derived platelet- rich plasma,16 embry-
onic artery CD133+ cells loaded with the Sirt1 agonist 
SRT172020 and knockout of Redox Enzyme p66Shc.15 
The interventions were reported to improve wound 
healing via multiple different mechanisms including 
increased collagen content, granulation tissue thick-
ness, myofibroblast differentiation and capillary density 
in addition to increased expression levels of vascular 
endothelial growth factor (VEGF- A), interleukin-8 
and basic fibroblast growth factor. Furthermore, these 
Table 2 Clinical relevance assessment of the included studies
Criteria
Study
14 15 16 17 18 19 20
Species 0 0 0 0 0 0 0
Was ischemia created in a limb as generally seen in 
patients?
1 1 1 1 1 1 1
Was the ischemia created via ligation of an iliac, femoral 
or saphenous or popliteal artery?
1 1 1 1 1 1 1
Was the blood flow assessed? 1 1 0 1 1 0 0
Was the wound located in the paw to mimic a foot ulcer 
seen in patients?
1 0 0 1 1 0 0
Did the animals have diabetes? 0 1 0 1 1 1 1
Did the animals have peripheral neuropathy? 0 0 0 0 0 0 0
Were the animals aged an equivalent of over 50 years of 
human age?
0 0* 0* 0 0* 0 0
Did the study report complete wound healing data? 1 0 0 1 1 0 0
Score of 9=100% 5 4 2 6 6 3 3




















are: first published as 10.1136/bm





5BMJ Open Diab Res Care 2020;8:e001676. doi:10.1136/bmjdrc-2020-001676
Pathophysiology/complications
interventions were reported to reduce apoptosis and 
leukocyte infiltration in addition to reducing expres-
sion levels of tumor necrosis factor (TNF) and β-catenin 
expression (table 3). Due to variations in interventions 
studied, meta- analyses were not possible. The risk of 
bias and reporting quality was considered high for 
three of these studies16 19 20 and moderate15 18 for two 
studies. The mean risk of bias and reporting quality 
score was 76.0%±13.0%. The clinical relevance of four 
of the studies was considered low15 16 19 20 and moderate 
for one study.18 The mean clinical relevance score was 
40.0%±16.8%.
Figure 1 Wound healing at day 7 (A), 14 (B) and 21 (C) following ischemic wound induction. Studies were grouped in relation 
to whether diabetes was induced are not. A random effects model was used for analysis. Heterogeneity was assessed using 
the I2 statistic. Pooled estimates of standard mean difference and 95% CIs were calculated using Review Manager 5.3.5. IV, 
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Heterogeneity, publication bias and consistency of meta-
analyses
All meta- analyses had very high degrees of heteroge-
neity between studies (figure 1). Funnel plots suggested 
a high risk of publication bias (online supplementary 
figures 5–8). In the leave one out sensitivity analyses, 
removal of individual studies did not affect the signifi-
cance of findings (online supplementary table 2).
DISCUSSION
This systematic review and meta- analysis suggests that hind 
limb ischemia delays wound healing in mice, rats and 
rabbits and can thus potentially model human ischemic 
ulcers. Induction of diabetes by STZ injection was included 
in some studies but did not significantly delay ischemic 
wound healing based on the meta- analysis. This finding 
likely reflects the small number of studies currently available. 
Findings were consistent in sensitivity analyses but there was 
noted to be a large amount of statistical heterogeneity and a 
high risk of publication bias.
The animal models reported did lack some features of 
human disease, such as the presence of older age and the 
generation of wounds in the periphery of the limb. The latter 
was only included in three studies, which created ulcers in 
the paws of rats.14 17 18 All the included studies used younger 
animals but patients presenting with ischemic ulcers are 
usually aged over 60 years.21 Given that angiogenesis and 
wound healing are impaired in older animals and humans, 
future studies would benefit from using older animals.22 23 
Other recommendations for the ideal ischemic ulcer model 
include induction of stable limb ischemia, which typically 
requires gradual artery occlusion,24 and consideration of 
inclusion of typical patient comorbidities, such as diabetes 
(online supplementary table 3). This is supported by a recent 
systematic review that suggested the need for refinement of 
currently used mouse models of diabetes- associated ulcers in 
order to make them more clinically relevant.25
Five different interventions were tested in the included 
studies and reported to successfully improve healing rate 
through mechanisms such as promoting angiogenesis, 
collagen deposition, re- epithelialization and increased 
expression levels of proliferative markers such as VEGF and 
increased anti- inflammatory cytokines such as interleukin-8 
in addition to reduction of leukocyte infiltration and 
reduced expression levels of inflammatory cytokines such as 
TNF15 16 18–20 (table 3). The risk of bias and reporting quality 
of three of these studies was considered high but none of the 
models used were considered to be highly clinically relevant. 
Only one of the studies reported randomization of treat-
ment groups and blinding of the outcome assessor.16 Many 
of the studies failed to assess blood flow16 19 20 did not create 
wounds at a peripheral site and failed to report complete 
wound closure.15 16 19 20 Due to these weaknesses and the 
lack of repeat testing of common interventions, it remains 
unclear how likely the findings of these studies are to be 
translatable to patients.
Table 3 Factors involved in wound healing as reported in the included studies
Reference Species
Reported factors that delayed 
wound healing Treatment
Reported factors that improved 
wound healing
14 Rat ↓ Myofibroblast quantification




15 Mice ↓ Collagen content
↓ Granulation tissue thickness
↑ Apoptosis
↑ c- myc and β-catenin expression
↓ Capillary density
P66Shc Knockout ↑ Collagen content
↑ Granulation tissue thickness
↓ Apoptosis
↓ c- myc and β-catenin expression
↑ Capillary density
16 Rabbit ↓ Myofibroblast differentiation Bone marrow aspirate & 
Platelet rich plasma
↑ Myofibroblast differentiation
17 Rats ↓ Myofibroblast differentiation
↓ Wound contraction
None NA
18 Rats ↓ Wound contraction and re- 
epithelialization
↓ Collagen deposition
Hyperbaric oxygen therapy ↑ Blood flow and wound closure
↑ Wound contraction and re- 
epithelialization
↑ Collagen deposition
19 Mice ↓ Capillary density
↑ Leukocyte infiltration
































are: first published as 10.1136/bm





7BMJ Open Diab Res Care 2020;8:e001676. doi:10.1136/bmjdrc-2020-001676
Pathophysiology/complications
A number of limitations of the research included in this 
systematic review should be acknowledged. Rodent skin 
anatomy differs from that of humans. Rodents have thin 
epidermis, loose skin adherence, dense hair which is thought 
to accelerate healing.26 Furthermore, the age of animals 
used in the included studies were equivalent to teenage 
humans which is not representative of the population that 
present with ischemic ulcers.27 The included studies also 
lack a number of important methods to reduce bias, such 
as blinding of outcome assessors. Improving the methods of 
preclinical ischemic ulcer research may lead to better trans-
lation of findings to patients.
In conclusion, previously reported models of ischemic 
ulceration have impaired wound healing representative 
of patients. Improvements in study design and models are 
possible to increase the likelihood of achieving findings 
which can be translated to patients.
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